Efruxifermin in Compensated Liver Cirrhosis Caused by MASH. Reply

N Engl J Med. 2025 Sep 11;393(10):10.1056/NEJMc2510444#sa2. doi: 10.1056/NEJMc2510444.

Authors

Mazen Noureddin¹, Reshma Shringarpure², Kitty Yale²

Affiliations

¹ Houston Methodist Hospital, Houston.
² Akero Therapeutics, South San Francisco, CA.

PMID: 40929640
DOI: 10.1056/NEJMc2510444

No abstract available

Publication types

Letter
Comment